Navigation Links
Mylan Reports Third Quarter 2013 Adjusted Diluted EPS of $0.82
Date:10/31/2013

nt prior period amounts of other revenue, cost of sales, operating expenses and the related EBITDA and Adjusted EBITDA have been reclassified to other (expense) income, net to conform to the presentation for the current period. The reclassificationshad no impact on the previously reported net earnings attributable to Mylan Inc. common shareholders. 

Below is a reconciliation of GAAP net earnings attributable to Mylan Inc. to adjusted EBITDA for the three and nine months ended September 30, 2013 and 2012 (in millions):

 Three Months EndedNine Months EndedSeptember 30,September 30,2013201220132012GAAP net earnings attributable to Mylan Inc.

$

158.9$

211.3$

443.5$

478.9Add adjustments:Net contribution attributable to the noncontrolling interest and equity method investees

5.85.515.214.1Income taxes

35.852.8108.6132.4Interest expense

74.076.1233.7234.1Depreciation and amortization

126.9171.2373.9417.8EBITDA

$

401.4$

516.9$

1,174.9$

1,277.3Add adjustments:Stock-based compensation expense

12.79.736.032.1Litigation settlements, net

(5.4)8.03.3(2.1)Restructuring & other special items

125.535.3224.3120.5Adjusted EBITDA

$

534.2$

569.9$

1,438.5$

1,427.8Conference CallMylan will host a conference call and live webcast, today, October 31, 2013, at 10:00 AM ET, in conjunction with the release of its financial results. The dial-in number to access the call is 877.402.3913 or 817.382.5964 for international callers. A replay will be available two hours after the calls completion for a limited time at 800.585.8367 or 404.537.3406 for international callers with access pass code 77498768. To access a live webcast of the call please log onto Mylan's website (www.mylan.com) at least 15 minutes before the event is to
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
2. Mylan to Speak at the Morgan Stanley Global Healthcare Unplugged Conference
3. Mylan to Speak at the Bank of America Merrill Lynch Global Healthcare Conference
4. Mylan Announces Completion of Transdermal Patch Facility Expansion Project in St. Albans, Vt.
5. Mylan Acquisition of Agila Receives Approval from Indias Foreign Investment Promotion Board and Cabinet Committee on Economic Affairs
6. Mylan Confirms Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
7. Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
8. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
9. Mylan to Host Investor Day on Aug. 1, 2013 in New York City
10. Roger Graham Named President of Mylan Specialty
11. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015  Abbott (NYSE: ABT ) announced ... multi-center, randomized trial comparing the safety and effectiveness of ... ® , Abbott,s market-leading, permanent drug eluting stent. The ... Japan and enrolled 400 people with coronary ... The results will be featured at a late-breaking session ...
(Date:9/1/2015)... Quebec , Sept. 1, 2015  Valeant ... TSX: VRX) today announced that its affiliate has ... which Valeant was granted an exclusive license to ... is an IL-17 receptor monoclonal antibody in development ... arthritis. Under the agreement, Valeant will hold the ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4Valeant And AstraZeneca To Partner On Brodalumab 2Valeant And AstraZeneca To Partner On Brodalumab 3Valeant And AstraZeneca To Partner On Brodalumab 4
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm ... investor-families have received permanent green cards (I-829 petition approval) from the USCIS through ... is the final step of the EB-5 visa process for immigrant investors to ...
(Date:9/1/2015)... Aventura, Florida (PRWEB) , ... September 01, 2015 ... ... across language barriers and international borders seldom arise at the most convenient time ... which is always ready to help. , Universal Translation Services has ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It is ... alliance is dedicated to the provision of quality addiction treatment and the ...
(Date:9/1/2015)... ... ... Elizabeth Callahan, MD, founder and medical director of SkinSmart Dermatology® , ... filler treatment for volume loss in the hands. RADIESSE provides an immediate volumizing effect ... delivering smooth, natural-looking results that can last up to one year in most patients. ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... has recently sponsored an educational workshop for physician assistants (PAs) practicing in orthopedics. ... Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic surgeon at ...
Breaking Medicine News(10 mins):Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 2Health News:Universal Translation Services Provides Quality Translations 24 Hours a Day Including Weekends 3Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3
... -- Among people with coronary stents, depression was linked to ... study period, researchers found. A coronary stent is a ... keep it open. Coronary arteries supply blood to the heart. ... with an average age 62, who underwent assessment for depression ...
... identify which skills and competencies are considered most critical ... to effectively manage opioid risk in patients treated for ... pain management, and addiction, Experts in this study identified ... in chronic pain patients as how to monitor opioids ...
... March 16 (HealthDay News) -- One man,s example hints at ... diseases before the patient actually gets sick. Researchers analyzed ... Snyder, and then used it to determine his risks for ... fragments of DNA -- and found that he was at ...
... EHEC crisis in Germany in 2011 proved that food brought ... life-threatening diseases. Nevertheless, there have been extremely few investigations ... EU along with food. The gap is now to ... almost three million Euro to cover the costs. Samples ...
... FRIDAY, March 16 (HealthDay News) -- Being unable to ... deadly outcome for older people, new research reveals. ... 52 and older, who completed a test of functional ... to understand health-related information. Specifically, the test assessed a ...
... 2012: Poor dental hygiene behaviours in patients with congenital ... with congenital heart disease floss, brush and visit the ... behaviours when it comes to alcohol, cigarettes and illicit ... congenital heart disease) also have poorer dental hygiene practices ...
Cached Medicine News:Health News:Depression Tied to Earlier Death in Heart Patients 2Health News:Study determines critical skills for PCPs to safely manage opioid risk in chronic pain patients 2Health News:Researcher Uses Genomics to Predict His Odds for Disease 2Health News:Dangerous stowaways: An EU project to look at the international spread of germs on food 2Health News:Poor Reading Skills Might Be Fatal for Older Folks 2Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 2Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 3Health News:Poor dental hygiene puts congenital heart disease patients at risk of further heart damage 4
Inquire...
Inquire...
... optical performance, the SZX7 is designed for ... every task, from routine preparations to advanced ... best zoom ratios in its class as ... and accurate reproduction of the original specimen ...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility....
Medicine Products: